Kai Teng

750 total citations
16 papers, 531 citations indexed

About

Kai Teng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kai Teng has authored 16 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kai Teng's work include Cancer Mechanisms and Therapy (2 papers), Microtubule and mitosis dynamics (2 papers) and Aortic aneurysm repair treatments (2 papers). Kai Teng is often cited by papers focused on Cancer Mechanisms and Therapy (2 papers), Microtubule and mitosis dynamics (2 papers) and Aortic aneurysm repair treatments (2 papers). Kai Teng collaborates with scholars based in China, United States and Hong Kong. Kai Teng's co-authors include Dan Xie, Muyan Cai, John G. Carson, Eugene S. Lee, Miaomiao Dai, Rui‐Hua Xu, Xin‐Yuan Guan, Zihao Feng, Jin‐Ling Duan and Wei Shi and has published in prestigious journals such as ACS Nano, Molecular Cancer and Journal of Vascular Surgery.

In The Last Decade

Kai Teng

15 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Teng China 11 282 167 164 91 73 16 531
Zhengwang Sun China 14 205 0.7× 141 0.8× 113 0.7× 135 1.5× 24 0.3× 46 532
Chun-Ying Qu China 14 271 1.0× 97 0.6× 152 0.9× 104 1.1× 13 0.2× 25 563
Haruhiko Satonaka Japan 13 148 0.5× 195 1.2× 93 0.6× 68 0.7× 18 0.2× 23 488
Jianwei Zhu China 15 322 1.1× 111 0.7× 187 1.1× 107 1.2× 8 0.1× 58 606
D. Matthew Gianferante United States 4 302 1.1× 172 1.0× 203 1.2× 103 1.1× 11 0.2× 8 513
Chen‐Song Huang China 15 373 1.3× 94 0.6× 208 1.3× 191 2.1× 16 0.2× 38 610
Laura July Canada 7 252 0.9× 148 0.9× 141 0.9× 339 3.7× 26 0.4× 9 623
Nan Du China 15 438 1.6× 148 0.9× 341 2.1× 167 1.8× 17 0.2× 27 713

Countries citing papers authored by Kai Teng

Since Specialization
Citations

This map shows the geographic impact of Kai Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Teng more than expected).

Fields of papers citing papers by Kai Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Teng. The network helps show where Kai Teng may publish in the future.

Co-authorship network of co-authors of Kai Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Teng. A scholar is included among the top collaborators of Kai Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Teng. Kai Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Teng, Kai, Hanlin Ma, Panpan Gai, Xuelian Zhao, & Gonghua Qi. (2025). SPHK1 enhances olaparib resistance in ovarian cancer through the NFκB/NRF2/ferroptosis pathway. Cell Death Discovery. 11(1). 29–29. 7 indexed citations
2.
Qi, Gonghua, et al.. (2025). TTK activates ATR through RPA2 phosphorylation to promote olaparib resistance in ovarian cancer. Communications Biology. 8(1). 1011–1011.
3.
Qi, Gonghua, Hanlin Ma, Kai Teng, et al.. (2024). SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway. APOPTOSIS. 30(1-2). 83–98. 3 indexed citations
4.
Zhou, Lele, Qun Guan, Jing‐Lan Kan, et al.. (2023). A Multifunctional Covalent Organic Framework Nanozyme for Promoting Ferroptotic Radiotherapy against Esophageal Cancer. ACS Nano. 17(20). 20445–20461. 50 indexed citations
5.
Duan, Jin‐Ling, Wei Chen, Juanjuan Xie, et al.. (2022). A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Molecular Cancer. 21(1). 93–93. 109 indexed citations
6.
Zhang, Chi, Wei Shi, Weipeng Sun, et al.. (2020). Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma. Theranostics. 10(20). 9066–9082. 37 indexed citations
7.
Shi, Wei, Miaomiao Dai, Chi Zhang, et al.. (2020). KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma. Protein & Cell. 12(10). 788–809. 83 indexed citations
8.
Teng, Kai, et al.. (2020). The Effect of Osteopathic Manipulative Treatment on Proprioception in Adults: A Pilot Study. 30(4). 11–19. 1 indexed citations
9.
Teng, Kai, Chi Zhang, Jiewei Chen, et al.. (2019). KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity. Journal of Experimental & Clinical Cancer Research. 38(1). 329–329. 50 indexed citations
10.
Teng, Kai, Yunlin Ye, Lei Tan, et al.. (2019). Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial–mesenchymal transition via Akt/GSK3β signaling. Cancer Science. 110(9). 2822–2833. 21 indexed citations
11.
12.
13.
Teng, Kai, et al.. (2012). PVSS4. Implementation of the Screen for Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act: A Five-Year Follow-up. Journal of Vascular Surgery. 55(6). 5S–5S. 1 indexed citations
14.
Teng, Kai, et al.. (2012). Outcomes of an abdominal aortic aneurysm screening program. Journal of Vascular Surgery. 57(2). 376–381. 36 indexed citations
15.
Xu, Rui‐Hua, et al.. (2010). Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumor Biology. 31(6). 633–641. 54 indexed citations
16.
Luo, Hui, et al.. (2009). [Prognosis of 84 intrahepatic cholangiocarcinoma patients].. PubMed. 28(5). 528–32. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengwang Sun Breakdown of academic impact, for papers by Chun-Ying Qu Breakdown of academic impact, for papers by Haruhiko Satonaka Breakdown of academic impact, for papers by Jianwei Zhu Breakdown of academic impact, for papers by D. Matthew Gianferante Breakdown of academic impact, for papers by Chen‐Song Huang Breakdown of academic impact, for papers by Laura July Breakdown of academic impact, for papers by Nan Du
Rankless by CCL
2026